| Title | Emerging trends in Abuse-Deterrent Formulations: Technological insights and Regulatory considerations |
|---|
| Faculty Authors | Dr. Derajram Benival | Impact Factor | 3.758 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Pharmaceutics | Paper Type | Review | Issue No | |
|---|
| Journal Name | Current Drug Delivery |
|---|
|
| Title | Laser activatable nanographene colloids for chemo-photothermal combined gene therapy of triple-negative breast cancer |
|---|
| Faculty Authors | Dr. Rakesh Kumar Tekade | Impact Factor | 7.328 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Pharmaceutics, Department of Natural Products | Paper Type | Research | Issue No | |
|---|
| Journal Name | Materials Science and Engineering: C |
|---|
|
| Title | A molecular perspective for the use of type IV tyrosine kinase inhibitors as anticancer therapeutics |
|---|
| Faculty Authors | Dr. Amit Shard | Impact Factor | 8.369 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Medicinal Chemistry | Paper Type | Review | Issue No | |
|---|
| Journal Name | Drug Discovery Today |
|---|
|
| Title | Chapter 8 Dendrimers: Properties and Applications in Biomedical Field |
|---|
| Faculty Authors | Dr. Rakesh Kumar Tekade | Impact Factor | N.A | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Pharmaceutics | Paper Type | Book Chapter Paper | Issue No | |
|---|
| Journal Name | Nil |
|---|
|
| Title | TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC |
|---|
| Faculty Authors | Dr. Siddheshwar Chauthe | Impact Factor | 6.575 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Natural Products | Paper Type | Research | Issue No | |
|---|
| Journal Name | Cancers |
|---|
|
| Title | Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview |
|---|
| Faculty Authors | Dr. Siddheshwar Chauthe | Impact Factor | 6.656 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Natural Products | Paper Type | Review | Issue No | |
|---|
| Journal Name | Phytomedicine |
|---|
|
| Title | LC-HRMS Studies on Ruxolitinib Degradation: A Comprehensive Approach during Drug Development, |
|---|
| Faculty Authors | Dr. Ravi Shah | Impact Factor | 3.532 | Year | 2021 |
|---|
| DOI Number | doi.org/10.1039/D1AY01915E | Page No | 480-490 | Volume No | 14 |
|---|
| Department | Department of Pharmaceutical Analysis | Paper Type | Research | Issue No | |
|---|
| Journal Name | Analytical Methods |
|---|
|
| Title | Recent Advances in Natural Product-Based NF‑κB Inhibitors as Anticancer and Anti-Inflammatory Agents |
|---|
| Faculty Authors | | Impact Factor | 2.329 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Medicinal Chemistry | Paper Type | Review | Issue No | |
|---|
| Journal Name | Medicinal Chemistry |
|---|
|
| Title | Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profile |
|---|
| Faculty Authors | Dr. Amit Shard | Impact Factor | 5.112 | Year | 2021 |
|---|
| DOI Number | | Page No | | Volume No | |
|---|
| Department | Department of Medicinal Chemistry, Department of Medical Devices, Department of Natural Products | Paper Type | Research | Issue No | |
|---|
| Journal Name | European Journal of Pharmaceutical Sciences |
|---|
|
| Title | Peptide-functionalised nanocarriers for bone-specific delivery of PTH (1-34) in osteoporosis |
|---|
| Faculty Authors | Dr. Derajram Benival | Impact Factor | | Year | 2021 |
|---|
| DOI Number | doi.org/10.2174/2468187312666211220112324 | Page No | 142 - 148 | Volume No | 11 |
|---|
| Department | Department of Pharmaceutics | Paper Type | Research | Issue No | 3 |
|---|
| Journal Name | Current Nanomedicine |
|---|
|
